Cipla launches inhalable insulin for diabetes careCipla has launched a new orally inhaled insulin powder for diabetes patients in India. This needle-free alternative to injections offers a ...
23 Dec, 2025, 12.09 AM IST
Cipla shares in focus after receiving CDSCO nod to launch inhalation insulinCipla has secured exclusive rights to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers ...
12 Dec, 2024, 08.14 AM IST
Cipla gets CDSCO nod to launch inhalation insulinCipla received approval from CDSCO to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers ...
11 Dec, 2024, 05.38 PM IST
Cipla scales up offerings, investments as it eyes global lung specialty leadershipDrugmaker Cipla said it is scaling up offerings and expanding access to medicines, inhaler devices, diagnostics, as it aspires to become th...
18 Nov, 2021, 07.35 PM IST
Amazon opens online pharmacy, shaking up another industryThe company opened an online pharmacy Tuesday, giving Amazon shoppers the chance to buy their medication and order refills on their phones ...
18 Nov, 2020, 12.17 PM IST
Suffering from type 2 diabetes? New treatments can help control blood glucose levelOn World Diabetes Day, here's a list of new medications that will make life simpler for diabetics.
14 Nov, 2018, 04.36 PM IST
Cipla’s inhalable insulin fails to get approval for trials on Indian patientsCipla had based its application to the panel on the bioequivalence studies with Exubra, an inhalation drug and device combination that was ...
06 Dec, 2016, 02.00 AM IST
Novo Nordisk searches for tablet to replace insulin shotsThe company that reaped nearly 80% of its $16 billion sales from insulin products last year is hopeful for a regulatory approval for its fi...
13 Sep, 2016, 07.57 AM IST
The Holy Grail: How Rani Therapeutics Is packing the insulin punch in pillsScientists couldn’t crack the science because enzymes in the stomach break down and digest the proteins, which are therefore not absorbed i...
23 May, 2016, 05.38 PM IST
Arvind Kejriwal has high blood sugar level, to start insulin course: Family doctorArvind Kejriwal, who has been dogged of late by health problems, was today examined by his family doctor at the Secretariat here.
27 Jan, 2014, 11.03 PM IST
- Pfizer in $200 million insulin deal with Biocon
Biocon received $200 million upfront from New York-based Pfizerwhich is re-entering the $14-billion global insulin market almost four years...
25 Feb, 2011, 05.48 AM IST
- Very bullish on Glenmark: Aunali Rupani, ARM Research
Next 5 years will see a big run up in all the pharma stocks in India especially R&D.
30 Sep, 2010, 11.11 AM IST
- Pfizer’s Q3 profit up on downsizing, higher sales
Pfizer, the world’s biggest drugmaker, said profit tripled because of higher sales of the pain pill Lyrica and lower costs from the 11,000 ...
22 Oct, 2008, 03.29 AM IST
- Pfizer warns of lung cancer link with inhaled insulin
US drugmakers Pfizer Inc and Nektar Therapeutics warned of cases of lung cancer in clinical trials of their inhaled insulin Exubera.
10 Apr, 2008, 09.14 AM IST
- First needle-free insulin soon
Biotechnology company Shreya Lifesciences has entered into an in-licensing agreement with US-based Generex Biotechnology Corp to market Ora...
02 Nov, 2007, 02.49 AM IST
- Pfizer's profit falls on costs to end diabetic treatment sales
Pfizer, the world’s largest drugmaker, said third-quarter profit fell 77% on costs for ending sales of the diabetes treatment Exubera and c...
19 Oct, 2007, 12.56 AM IST
- Pfizer unveils first insulin inhaler in US
After more than two decades of daily needle injections to treat his diabetes, Ken Wagner says he is eager to try Exubera, the first inhaled...
25 Jul, 2006, 12.00 AM IST